Search alternatives:
significant cause » significant change (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
cause increase » causes increased (Expand Search), cases increased (Expand Search), could increase (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), we decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
significant cause » significant change (Expand Search), significant changes (Expand Search), significant gap (Expand Search)
cause increase » causes increased (Expand Search), cases increased (Expand Search), could increase (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), we decrease (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
-
141
-
142
Table1_One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes.docx
Published 2024“…</p><p>Results: Beyond the improvement of BMI and lung function with LI treatment and even more with ETI, we found that the 3 years of LI treatment significantly improved liver function parameters (total and conjugated bilirubin, ALT, AP, and GGT), while the subsequent ETI treatment caused a significant increase of such parameters.…”
-
143
Table2_One year of treatment with elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis homozygous for the F508del mutation causes a significant increase in liver biochemical indexes.docx
Published 2024“…</p><p>Results: Beyond the improvement of BMI and lung function with LI treatment and even more with ETI, we found that the 3 years of LI treatment significantly improved liver function parameters (total and conjugated bilirubin, ALT, AP, and GGT), while the subsequent ETI treatment caused a significant increase of such parameters.…”
-
144
-
145
A possible cause of epistaxis: increased masked hypertension prevalence in patients with epistaxis
Published 2022“…Conclusion This study demonstrates increased masked hypertension prevalence in patients with epistaxis. …”
-
146
-
147
Histological studies of lungs stained with Cy3-coupled anti-ceramide antibodies.
Published 2022Subjects: -
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
Histological studies of lungs stained with Cy3-coupled anti-sphingosine antibodies.
Published 2022Subjects: -
156
-
157
-
158
-
159
-
160